Salts of Clopidogrel: Investigation to Ensure Clinical Equivalence: A 12-Month Randomized Clinical Trial

Conclusion:
The efficacy and safety of CB administered for 12 months for the secondary prevention of atherothrombotic events are similar to that of CHS. (Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence, SCIENCE trial; ClinicalTrials.gov Identifier:NCT02126982).

Source: Journal of Cardiovascular Pharmacology and Therapeutics - October 4, 2016 Category: Cardiology Authors: Ntalas, I. V., Kalantzi, K. I., Tsoumani, M. E., Bourdakis, A., Charmpas, C., Christogiannis, Z., Dimoulis, N., Draganigos, A., Efthimiadis, I., Giannakoulas, G., Giatrakos, I., Giogiakas, V., Goumas, G., Hatziathanasiou, G., Kazakos, E., Kipouridis, N., Tags: Clinical Study Source Type: research